A New Horizon: Finding Lasting Hope Beyond Depression's Shadows
Tonix Pharmaceuticals Gets the Go-Ahead: TNX-102 Enters Clinical Development for Major Depression
Cracking the Code: The Single Gene That Could Redefine Our Understanding of Mental Illness
The Whisper of Our Genes: Unraveling Schizophrenia's Ancient Blueprint
Wells Fargo Crowns Axsome Therapeutics a Biotech Heavyweight with 'Overweight' Rating on Blockbuster Alzheimer's Potential